Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Oncternal Therapeutics, Inc. has filed 1,606 SEC EDGAR filings since 21 Aug 2003

SEC filing history

Showing 876-900 of 1,000 matching filings.

Per page
25
Current page
36
SC 13D/A File 005-79588

SCHEDULE 13D/A

Filing date
29 Aug 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Aug 2011
Reporting date
19 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

FORM 8-K

Filing date
09 Aug 2011
Reporting date
09 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Aug 2011
Reporting date
04 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

FORM 8-K

Filing date
04 Aug 2011
Reporting date
04 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jul 2011
Reporting date
01 Jul 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jul 2011
Reporting date
01 Jul 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jul 2011
Reporting date
01 Jul 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jul 2011
Reporting date
01 Jul 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jul 2011
Reporting date
01 Jul 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jul 2011
Reporting date
01 Jul 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-79588

SC 13D/A

Filing date
05 Jul 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Jun 2011
Reporting date
28 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

FORM 8-K

Filing date
23 Jun 2011
Reporting date
23 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-174396

424B5

Filing date
23 Jun 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-174396

424B5

Filing date
22 Jun 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

FORM 8-K

Filing date
20 Jun 2011
Reporting date
20 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Jun 2011
Reporting date
06 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

FORM 8-K

Filing date
06 Jun 2011
Reporting date
06 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-174396

EFFECT filing

Filing date
02 Jun 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

FORM 8-K

Filing date
01 Jun 2011
Reporting date
01 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-174396

FORM S-3

Filing date
20 May 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 May 2011
Reporting date
06 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 May 2011
Reporting date
06 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .